Current Therapeutic Approaches for Early-Stage HER2-Positive Breast Cancer

Download this slideset with key data on optimal adjuvant therapy and extended adjuvant therapy for patients with early-stage HER2-positive breast cancer. Experts discuss how to identify which patients are most likely to benefit from the available treatment strategies.

Share

Program Content

No activities added yet

Supporters

Supported by an educational grant from

Puma Biotechnology, Inc.